Kim Saverno
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes 4
- Family Practice top 10%
- Medication Adherence and Compliance 4
- Medical Terminology top 10%
- Toxicology top 10%
-
- Health Systems, Economic Evaluations, Quality of Life 7
- Pharmaceutical Economics and Policy 4
- Economic and Financial Impacts of Cancer 3
-
- Breast Cancer Treatment Studies 5
-
- Pharmaceutical studies and practices 4
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Daniel C. MaloneAmy J. GrizzleLisa E. HinesAnn M. TaylorTerri WarholakUwe SiebertChad MoretzYunping Zhou
- Journals
- Journal of Clinical Oncology (3 papers)Annals of Oncology (1 paper)Journal of the American Medical Informatics Association (1 paper)
- Partner nations
- United StatesAustriaUnited Kingdom
In The Last Decade
Kim Saverno
27 papers receiving 485 citations
Peers
Comparison fields: 5 of 83
- Geriatrics and Gerontology 108
- Family Practice 35
- Medical Terminology 4
- Health Information Management 55
- Toxicology 25
Countries citing papers authored by Kim Saverno
This map shows the geographic impact of Kim Saverno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Saverno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Saverno more than expected).
Fields of papers citing papers by Kim Saverno
This network shows the impact of papers produced by Kim Saverno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Saverno. The network helps show where Kim Saverno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kim Saverno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 30 | |
| 5 | 2021 | 2 | |
| 6 | 2015 | 70 | |
| 7 | 2015 | 8 | |
| 8 | 2015 | 25 | |
| 9 | 2015 | 102 | |
| 10 | 2014 | 17 | |
| 11 | Consideration of international generic distribution policies on patient outcomes in the United States and Germany. | 2014 | 3 |
| 12 | 2013 | 4 | |
| 13 | 2013 | 1 | |
| 14 | 2013 | 1 | |
| 15 | 2012 | 1 | |
| 16 | 2012 | 2 | |
| 17 | 2011 | 8 | |
| 18 | 2011 | 20 | |
| 19 | 2010 | 92 | |
| 20 | 2009 | 18 |
About Kim Saverno
Kim Saverno is a scholar working on Family Practice, Issues, ethics and legal aspects and Geriatrics and Gerontology, having authored 29 papers that have together received 500 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Breast Cancer Treatment Studies (5 papers), Medication Adherence and Compliance (4 papers), Pharmaceutical Economics and Policy (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Pharmaceutical studies and practices (4 papers), Advanced Breast Cancer Therapies (3 papers) and Economic and Financial Impacts of Cancer (3 papers). The work is most often cited by research in Geriatrics and Gerontology (108 citations), Family Practice (35 citations) and Medical Terminology (4 citations). Kim Saverno has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Daniel C. Malone, Amy J. Grizzle, Lisa E. Hines, Ann M. Taylor, Terri Warholak, Uwe Siebert, Chad Moretz, Yunping Zhou, Gagan Jain and Amol D. Dhamane. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of the American Medical Informatics Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.